Skip to main content

Volume 5 Supplement 1

Proceedings of the Bio-Ontologies Special Interest Group 2013


Edited by Larisa N Soldatova, Philippe Rocca-Serra, Michel Dumontier, Nigam H Shah

Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. Articles have undergone the journal's standard peer review process for supplements. The Supplement Editors declare that they have no competing interests.

Bio-Ontologies Special Interest Group 2013.

Berlin, Germany20 July 2013

  1. Over the 16 years, the Bio-Ontologies SIG at ISMB has provided a forum for vibrant discussions of the latest and most innovative advances in the research area of bio-ontologies, its applications to biomedicine...

    Authors: Larisa N Soldatova, Philippe Rocca-Serra, Michel Dumontier and Nigam H Shah
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):I1
  2. Accounts of evidence are vital to evaluate and reproduce scientific findings and integrate data on an informed basis. Currently, such accounts are often inadequate, unstandardized and inaccessible for computat...

    Authors: Christian Bölling, Michael Weidlich and Hermann-Georg Holzhütter
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S1
  3. Ontologies encode relationships within a domain in robust data structures that can be used to annotate data objects, including scientific papers, in ways that ease tasks such as search and meta-analysis. Howev...

    Authors: Chayan Chakrabarti, Thomas B Jones, George F Luger, Jiawei F Xu, Matthew D Turner, Angela R Laird and Jessica A Turner
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S2
  4. With the advent of inexpensive assay technologies, there has been an unprecedented growth in genomics data as well as the number of databases in which it is stored. In these databases, sample annotation using ...

    Authors: Emily Merrill, Stéphane Corlosquet, Paolo Ciccarese, Tim Clark and Sudeshna Das
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S3
  5. The molecular etiology is still to be identified for about half of the currently described Mendelian diseases in humans, thereby hindering efforts to find treatments or preventive measures. Advances, such as n...

    Authors: Anika Oellrich, Sebastian Koehler, Nicole Washington, Chris Mungall, Suzanna Lewis, Melissa Haendel, Peter N Robinson and Damian Smedley
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S4
  6. The lack of established standards to describe and annotate biological assays and screening outcomes in the domain of drug and chemical probe discovery is a severe limitation to utilize public and proprietary d...

    Authors: Saminda Abeyruwan, Uma D Vempati, Hande Küçük-McGinty, Ubbo Visser, Amar Koleti, Ahsan Mir, Kunie Sakurai, Caty Chung, Joshua A Bittker, Paul A Clemons, Steve Brudz, Anosha Siripala, Arturo J Morales, Martin Romacker, David Twomey, Svetlana Bureeva…
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S5
  7. Matching and comparing sequence annotations of different reference sequences is vital to genomics research, yet many annotation formats do not specify the reference sequence types or versions used. This makes ...

    Authors: Zuotian Tatum, Marco Roos, Andrew P Gibson, Peter EM Taschner, Mark Thompson, Erik A Schultes and Jeroen FJ Laros
    Citation: Journal of Biomedical Semantics 2014 5(Suppl 1):S6

Annual Journal Metrics

  • 2022 Citation Impact
    1.9 - 2-year Impact Factor
    2.6 - 5-year Impact Factor
    0.870 - SNIP (Source Normalized Impact per Paper)
    0.697 - SJR (SCImago Journal Rank)

    2023 Speed
    23 days submission to first editorial decision for all manuscripts (Median)
    265 days submission to accept (Median)

    2023 Usage 
    206 Altmetric mentions